Literature DB >> 21294654

Epithelial barriers in intestinal inflammation.

Lena J John1, Michael Fromm, Jörg-Dieter Schulzke.   

Abstract

The gastrointestinal epithelium transports solutes and water between lumen and blood and at the same time forms a barrier between these compartments. This highly selective and regulated barrier permits ions, water, and nutrients to be absorbed, but normally restricts the passage of harmful molecules, bacteria, viruses and other pathogens. During inflammation, the intestinal barrier can be disrupted, indicated by a decrease in transcellular electrical resistance and an increase in paracellular permeability for tracers of different size. Such inflammatory processes are accompanied by increased oxidative stress, which in turn can impair the epithelial barrier. In this review, we discuss the role of inflammatory oxidative stress on barrier function with special attention on the epithelial tight junctions. Diseases discussed causing barrier changes include the inflammatory bowel diseases Crohn's disease, ulcerative colitis, and microscopic colitis, the autoimmune disorder celiac disease, and gastrointestinal infections. In addition, the main cytokines responsible for these effects and their role during oxidative stress and intestinal inflammation will be discussed, as well as therapeutic approaches and their mode of action.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294654     DOI: 10.1089/ars.2011.3892

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  55 in total

1.  Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.

Authors:  J Luettig; R Rosenthal; C Barmeyer; J D Schulzke
Journal:  Tissue Barriers       Date:  2015-04-03

Review 2.  New targets for mucosal healing and therapy in inflammatory bowel diseases.

Authors:  M F Neurath
Journal:  Mucosal Immunol       Date:  2013-10-02       Impact factor: 7.313

3.  Claudin-3 and occludin tissue content in the glands of colonic mucosa with and without a fecal stream.

Authors:  Carlos Augusto Real Martinez; Fabio Guilherme Caserta Maryssael de Campos; Viviel Rodrigo José de Carvalho; Caroline de Castro Ferreira; Murilo Rocha Rodrigues; Daniela Tiemi Sato; José Aires Pereira
Journal:  J Mol Histol       Date:  2015-02-04       Impact factor: 2.611

4.  Ascorbic acid inhibits cadmium-induced disruption of the blood-testis barrier by regulating oxidative stress-mediated p38 MAPK pathways.

Authors:  Na Chen; Ping Su; Mei Wang; Ya-Min Li
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-22       Impact factor: 4.223

5.  Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

Authors:  R E Vandenbroucke; I Vanlaere; F Van Hauwermeiren; E Van Wonterghem; C Wilson; C Libert
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

Review 6.  Claudins: control of barrier function and regulation in response to oxidant stress.

Authors:  Christian E Overgaard; Brandy L Daugherty; Leslie A Mitchell; Michael Koval
Journal:  Antioxid Redox Signal       Date:  2011-05-09       Impact factor: 8.401

Review 7.  Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.

Authors:  Nina A Hering; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

Review 8.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

9.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

Review 10.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.